TeselaGen is accelerating the design and fabrication of DNA with synthetic biology software.
Sign up today and learn more about TeselaGen Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About TeselaGen Stock
TeselaGen is building a rapid prototyping system for fast bio-based construction of sustainably sourced chemicals, therapeutic medicines, and novel vaccines. Their customers are biopharmaceutical and bioindustrial companies like Amgen and Genomatica. Their bioCAD/CAM system is based on technology exclusively licensed from Lawrence Berkeley National Lab and is being beta tested by hundreds of users.
Founder and Chief Scientific Officer
Founder & CEO
Founder & CTO